Published in Neth J Med on January 01, 1985
Early clinical complications after ABO-incompatible live-donor kidney transplantation: a national study of Medicare-insured recipients. Transplantation (2014) 1.04
The role of genetically engineered pigs in xenotransplantation research. J Pathol (2015) 0.87
Mechanism of accommodation in a sensitized human leukocyte antigen transgenic murine cardiac transplant model. Transplantation (2012) 0.80
Short-term results of ABO-incompatible living donor kidney transplantation: comparison with ABO-compatible grafts. J Korean Surg Soc (2011) 0.79
ABO-Incompatible Kidney Transplantation. Front Immunol (2017) 0.75
Synthetic blood group antigens for anti-A removal device and their interaction with monoclonal anti-A IgM. Transpl Immunol (2006) 0.75
Results of a multicenter prospective clinical study in Japan for evaluating efficacy and safety of desensitization protocol based on rituximab in ABO-incompatible kidney transplantation. Clin Exp Nephrol (2016) 0.75
Genetic studies into inherited and sporadic hemolytic uremic syndrome. Kidney Int (1998) 4.03
X-linked Alport syndrome: natural history in 195 families and genotype- phenotype correlations in males. J Am Soc Nephrol (2000) 2.71
Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation. International Valacyclovir Cytomegalovirus Prophylaxis Transplantation Study Group. N Engl J Med (1999) 2.33
A randomized double-blind, multicenter plasma concentration controlled study of the safety and efficacy of oral mycophenolate mofetil for the prevention of acute rejection after kidney transplantation. Transplantation (1999) 2.27
Identification of mutations in the alpha 3(IV) and alpha 4(IV) collagen genes in autosomal recessive Alport syndrome. Nat Genet (1994) 2.12
Urothelial lesions in Chinese-herb nephropathy. Am J Kidney Dis (1999) 2.05
Digital necrosis associated with chronic myeloid leukemia: a rare paraneoplastic phenomenon. Acta Clin Belg (1995) 1.95
Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection: a report of the European Tacrolimus Multicenter Renal Study Group. Transplantation (1997) 1.90
Role of the YadA protein in prevention of opsonization of Yersinia enterocolitica by C3b molecules. Infect Immun (1993) 1.86
Acquired immunodeficiency syndrome in African patients. N Engl J Med (1984) 1.70
Multiparameter immune profiling of operational tolerance in liver transplantation. Am J Transplant (2007) 1.69
IMx tacrolimus II vs IMx tacrolimus microparticle enzyme immunoassay evaluated in renal and hepatic transplant patients. Clin Chem (1997) 1.67
Safe preservation of human renal cadaver transplants by Euro-Collins solution up to 50 hours. Transplant Proc (1981) 1.50
Age-related changes in human blood lymphocyte subpopulations. II. Varying kinetics of percentage and absolute count measurements. Clin Immunol Immunopathol (1994) 1.47
The pharmacokinetic-pharmacodynamic relationship for mycophenolate mofetil in renal transplantation. Clin Pharmacol Ther (1998) 1.42
No association between Alport's syndrome and antithyroid antibodies. Nephrol Dial Transplant (1992) 1.38
Chinese herbs nephropathy: a clue to Balkan endemic nephropathy? Kidney Int (1994) 1.38
Technetium-99m L,L-ethylenedicysteine clearance and correlation with iodine-125 orthoiodohippurate for the determination of effective renal plasma flow. Eur J Nucl Med (1996) 1.37
Present experiences in a series of 26 ABO-incompatible living donor renal allografts. Transplant Proc (1987) 1.35
Sirolimus in association with mycophenolate mofetil induction for the prevention of acute graft rejection in renal allograft recipients. Transplantation (2000) 1.33
Identification of a locus for autosomal dominant polycystic liver disease, on chromosome 19p13.2-13.1. Am J Hum Genet (2000) 1.24
Modifier effect of ENOS in autosomal dominant polycystic kidney disease. Hum Mol Genet (2002) 1.20
An outbreak of Ochrobactrum anthropi bacteraemia in five organ transplant patients. J Hosp Infect (1994) 1.16
Autosomal recessive Alport syndrome: immunohistochemical study of type IV collagen chain distribution. Kidney Int (1995) 1.16
Bone marrow transplantation in sickle cell anaemia. Arch Dis Child (1991) 1.14
Autosomal recessive polycystic kidney disease in adulthood. Nephrol Dial Transplant (2001) 1.11
Twelve-month evaluation of the clinical pharmacokinetics of total and free mycophenolic acid and its glucuronide metabolites in renal allograft recipients on low dose tacrolimus in combination with mycophenolate mofetil. Ther Drug Monit (2003) 1.10
Bedside transfusion errors. A prospective survey by the Belgium SAnGUIS Group. Vox Sang (1994) 1.08
Induction versus noninduction in renal transplant recipients with tacrolimus-based immunosuppression. Transplantation (2001) 1.08
Correlation of mycophenolic acid pharmacokinetic parameters with side effects in kidney transplant patients treated with mycophenolate mofetil. Clin Chem (2001) 1.06
Renal side effects of nonsteroidal antiinflammatory drugs: clinical relevance. Am J Kidney Dis (1986) 1.06
A new hematologic syndrome with a distinct karyotype: the 5 q--chromosome. Blood (1975) 1.05
Genetics of hypercalciuric stone forming diseases. Kidney Int (2007) 1.04
The interaction between clarithromycin and cyclosporine in kidney transplant recipients. Transplantation (1994) 1.03
Outcome of patients with tuberous sclerosis after renal transplantation. Transplantation (1990) 1.02
Long-term effect of hbs antigenemia on patient survival after renal transplantation. N Engl J Med (1977) 1.01
Combined immunosuppressive therapy with cyclosporin A and azathioprine. A synergistic effect in three of four experimental models. Transplantation (1982) 1.01
Video-assisted neck exploration for primary and secondary hyperparathyroidism: initial experience. Surg Endosc (2001) 0.98
Autosomal-dominant periodic fever with AA amyloidosis: Novel mutation in tumor necrosis factor receptor 1 gene Rapid Communication. Kidney Int (2001) 0.98
[Current state of renal transplantation in Belgium]. Acta Chir Belg (1970) 0.97
Multiple spontaneous ruptures of tendons in renal transplant recipient. Br Med J (Clin Res Ed) (1984) 0.96
Adult porcine islet transplantation in baboons treated with conventional immunosuppression or a non-myeloablative regimen and CD154 blockade. Xenotransplantation (2002) 0.96
Detection of Mycobacterium avium subsp. paratuberculosis in infected tissues by new species-specific immunohistological procedures. Clin Diagn Lab Immunol (1998) 0.96
Familial juvenile hyperuricemic nephropathy and autosomal dominant medullary cystic kidney disease type 2: two facets of the same disease? J Am Soc Nephrol (2001) 0.95
Intracranial aneurysms in autosomal dominant polycystic kidney disease. Kidney Int (1994) 0.94
Increase of physical activity level after successful renal transplantation: a 5 year follow-up study. Nephrol Dial Transplant (2001) 0.94
Hypertension after renal transplantation. Br Med J (1976) 0.94
Urothelial malignancy in nephropathy due to Chinese herbs. Lancet (1994) 0.94
Course of Henoch-Schönlein nephritis after renal transplantation. Report on ten patients and review of the literature. Transplantation (1994) 0.94
Pharmacokinetic basis for the efficient and safe use of low-dose mycophenolate mofetil in combination with tacrolimus in kidney transplantation. Clin Chem (2001) 0.94
Fundus changes in membranoproliferative glomerulonephritis type II. A fluorescein angiographic study of 23 patients. Graefes Arch Clin Exp Ophthalmol (1991) 0.93
Recurrent fulminant anti-glomerular basement membrane nephritis at a 7-year interval. Am J Kidney Dis (1998) 0.92
Recent advances in the clinical management of autosomal-dominant polycystic kidney disease. QJM (1996) 0.92
Influence of body mass index, sex and age on serum alanine aminotransferase (ALT) level in healthy blood donors. Acta Gastroenterol Belg (1999) 0.92
Complications of autosomal dominant polycystic kidney disease in 50 haemodialysed patients. A case-control study. The U.C.L. Collaborative Group. Nephrol Dial Transplant (1996) 0.90
HLA gene and haplotype frequencies in spina bifida. Population and family studies. Tissue Antigens (1977) 0.90
Recurrence of membranous nephropathy after renal transplantation: probability, outcome and risk factors. Clin Nephrol (1998) 0.90
Cyclosporin-diltiazem interaction. Lancet (1986) 0.90
Meningococcal purpura: report of 19 patients treated with heparin. J Pediatr (1973) 0.89
Acute colonic complications after kidney transplantation. Acta Chir Belg (1995) 0.89
Resting B cells can act as antigen presenting cells in vivo and induce antibody responses. Int Immunol (1993) 0.89
Pancreas transplantation for treatment of generalized allergy to human insulin in type 1 diabetes. Transplant Proc (2005) 0.89
Pauci-immune necrotizing and crescentic glomerulonephritis in a patient with systemic lupus erythematosus. Clin Nephrol (2008) 0.89
Nickel contact sensitivity in women and HLA antigens. Arch Dermatol Res (1980) 0.89
Spontaneous 3H-thymidine incorporation by circulating lymphocytes of normal subjects: relative proportion of T and B cells. Int Arch Allergy Appl Immunol (1977) 0.89
Norfloxacin and cyclosporine--a safe combination. Transplantation (1989) 0.89
Contributions of the video-assisted approach to thyroid and parathyroid surgery. Acta Chir Belg (2002) 0.89
A combined HPLC-ELISA evaluation of FK 506 in transplant patients. Transplant Proc (1991) 0.87
Myocardial revascularization in patients on renal replacement therapy. Clin Nephrol (1991) 0.87
Aquaporin-1 and endothelial nitric oxide synthase expression in capillary endothelia of human peritoneum. Am J Physiol (1998) 0.87
Prospective evaluation of thoracic-duct drainage in the treatment of respiratory failure complicating severe acute pancreatitis. Intensive Care Med (1989) 0.86
Epiphyseal osteonecrosis in transplanted patients: effect of surgical treatment. Proc Eur Dial Transplant Assoc (1972) 0.85
ABO-incompatible orthotopic liver allografting in urgent indications. Surg Gynecol Obstet (1992) 0.84
Malakoplakia of the caecum in a kidney-transplant recipient: presentation as acute tumoral perforation and fatal outcome. Transpl Int (1999) 0.84
Cyclosporin A for immunosuppression: observations in rat heart, pancreas, and islet allograft models and in human renal and pancreas transplantation. Diabetes (1982) 0.84
Mutation detection in the repeated part of the PKD1 gene. Am J Hum Genet (1997) 0.84
Allogeneic or autologous bone marrow transplantation for acute non-lymphocytic leukemia in first remission. Bone Marrow Transplant (1991) 0.84
Evaluation in patients with Alport syndrome of knowledge of the disease and attitudes toward prenatal diagnosis. Clin Nephrol (1994) 0.84
Maximal hydration during anesthesia increases pulmonary arterial pressures and improves early function of human renal transplants. Transplantation (1982) 0.84
Orbital metastasis as primary manifestation of thyroid carcinoma. Thyroid (2000) 0.83
Effectiveness of oral acyclovir prophylaxis in renal transplant recipients. Transplant Proc (1987) 0.83